Intraoperative Superior Hypogastric Plexus Block For Pain Relief During Cesarean-Section

Intraoperative Superior Hypogastric Plexus Block For Pain Relief During Cesarean-Section: A Prospective Case-Control Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03460093

Enrollment

Registered

2018-03-09

Start date

2018-03-15

Completion date

2019-03-15

Last updated

2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior Hypogastric Plexus Block

Keywords

nerve blockade, hypogastric plexus, cesarean section

Brief summary

PURPOSE: to evaluate the efficacy of superior hypogastric plexus block for pain relief after cesarean section

Detailed description

Superior hypogastric plexus block(SHPB) for pain relief is routinely implemented in cesarean section operations at H.S.U Kocaeli Derince Education and Research Hospital. The implementation of this procedure depends on the clinical situation of the patient, the preference of the surgeon and the anesthesiologist, the course of the operation, and whether the patient wishes or not. Superior hypogastric plexus block is performed with 0.25 % bupivacaine 30 ml injected under peritoneum above promontorium. This is a prospective case-control study. The sample consisted of 60 women having cesarean-section with general anesthesia at H.S.U Kocaeli Derince Education and Research Hospital divided into two groups: the first group having superior hypogastric plexus block for pain relief and the control group not having superior hypogastric plexus block. All participants signed an informed consent and the study was approved by the Ethics Committee of Kocaeli University ( KUGOKAEK 2017/270). The sample size was calculated with G Power 3.1 program. With ki-square Goodness-of-fit test α:0.05 ,power 95% ,effect size 0.5 total sample size was calculated 52, including 26 in case group and 26 in control group. Women having cesarean-section with spinal anesthesia, women with known bupivacaine allergy, women with anxiety-depression disorder, women with known fibromyalgia were not enrolled to the study. Age, BMI(body mass index), education status, VAS (visual analog scale) scores ,the amount of analgesic used and the hour of gas extraction and bowel movement will be recorded.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Pregnant women having cesarean-section operation at H.S.U Kocaeli Derince Education and Research Hospital with general anesthesia, * Women agree to participate in the study, * Literate women.

Exclusion criteria

* Women having cesarean-section with spinal anesthesia, * Women with known bupivacaine and NSAIDS allergy, * Women with anxiety-depression disorder, * Women with known fibromyalgia. * Insufficient ability to understand information in Turkish

Design outcomes

Primary

Measure	Time frame	Description
postoperative pain score	postoperative 1. hour	postoperative pain score evaluated with Visual Analog Scale

Secondary

Measure	Time frame	Description
postoperative analgesic consumption	postoperative 48 hours	the amount of analgesic used (NSAIDs...) for pain relief after operation
postoperative passing of gas and bowel movements	postoperative 48 hours	the hour of postoperative gas extraction and bowel movements

Countries

Turkey (Türkiye)

Outcome results